The Effect of Chocolate on Vascular Function of Endurance Runners
Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · May 31, 2024
Trial Information
Current as of February 18, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Participants will be male endurance runners who will receive both black and white chocolate interventions. Arterial stiffness, cardiovascular parameters, respiratory parameters, and running performance will be assessed before and after each intervention period. The study will involve a two-week intervention period for each type of chocolate, with a washout period in between. The primary outcome measure will be arterial stiffness, while secondary outcome measures will include cardiovascular and respiratory parameters, as well as running performance. The study is expected to provide insights ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Gender: Male
- • Age: 25-55 years
- • Healthy status
- • Active endurance runner
- • Regular physical activity (at least 3 times per week)
- • Availability on specific days and times for research sessions
- • Willingness and consistency
- Exclusion Criteria:
- • Allergies or Intolerances: Participants with known allergies or intolerances to chocolate or any of its ingredients.
- • Cardiovascular Diseases: Participants with known cardiovascular diseases or history of cardiac episodes.
- • Metabolic Disorders: Individuals with diabetes or other metabolic disorders that may affect glucose and insulin metabolism.
- • Contradictory Diet: Individuals following specific diets that may affect the study, such as high or low flavonoid diets.
- • Medication Use: Individuals taking medications that affect vascular function, such as antihypertensives or anticoagulants.
- • Smoking: Smokers or individuals who have quit smoking within the last six months.
- • Substance Abuse: Individuals with a history of alcohol or substance abuse.
- • Patients with Chronic Diseases: Individuals with serious chronic diseases that may affect the study outcomes.
- • Participation in Other Studies: Individuals participating in other clinical trials or research that may affect the study outcomes.
- • Physical Condition: Individuals who are not regular runners or who do not exercise regularly at a level similar to other participants.
Trial Officials
Evangelia Kouidi, Professor
Principal Investigator
Aristotle University Of Thessaloniki
About Aristotle University Of Thessaloniki
Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thessaloniki, , Greece
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0